Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
The gut microbiome is widely viewed as an exciting new treasure trove of medical insight. But the skin microbiome holds plenty of its own potential, including for patients…
Genetic testing for Parkinson’s risks can be useful to people with and without the disease. It can also help advance research into the complex condition. Although the testing…
A new study has refreshed decades-old statistical models for Parkinson’s disease, and in the process discovered that almost 1 million Americans will have the disease in 2020—more than…
